Most of my academic training has focused on characterizing the influence of genetic and non-genetic (primarily modifiable exposures) factors on susceptibility and disease manifestation of multiple sclerosis (MS).
My current research spans understanding the etiology and pathology of MS from the micro- to the macro-level. For example, investigating whether a diagnostic signature for MS can be derived from readily available technologies (i.e. metabolomic assays), improving the phenotyping of the disease (which is critical for prognostication and the development of novel therapeutics), and describing patterns in healthcare utilization.
I also conduct research in other neurological and autoimmune diseases, such as Parksinson’s Disease, stroke, neuromyelitis optica and tranverse myelitis.
